Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Total Current Assets
|
Adaptive Biotechnologies Corp
Total Current Assets Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Total Current Assets
$374m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Assets
$24.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Current Assets
$14.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Current Assets
$1.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Assets
$4.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Assets
$5.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Adaptive Biotechnologies Corp's Total Current Assets?
Total Current Assets
374m
USD
374m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Current Assets amounts to 374m USD.
What is Adaptive Biotechnologies Corp's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-4%
-4%
Over the last year, the Total Current Assets growth was -25%. The average annual Total Current Assets growth rates for Adaptive Biotechnologies Corp have been -21% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
